Programmed death ligand-1 (PD-L1) is an important immune checkpoint molecule highly expressed in tumor tissues that transduces immunosuppressive signals to suppress the antitumor efficacy of immune cells through PD-L1 binding to programmed cell death protein-1 (PD-1) on activated T cells [7, 8]. This evidence concerns the gene PDCD1 and neoplasm.